These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16115890)

  • 1. Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells.
    Fujiwara Y; Sardar V; Tokumura A; Baker D; Murakami-Murofushi K; Parrill A; Tigyi G
    J Biol Chem; 2005 Oct; 280(41):35038-50. PubMed ID: 16115890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors.
    Valentine WJ; Fells JI; Perygin DH; Mujahid S; Yokoyama K; Fujiwara Y; Tsukahara R; Van Brocklyn JR; Parrill AL; Tigyi G
    J Biol Chem; 2008 May; 283(18):12175-87. PubMed ID: 18316373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
    Xu Y; Aoki J; Shimizu K; Umezu-Goto M; Hama K; Takanezawa Y; Yu S; Mills GB; Arai H; Qian L; Prestwich GD
    J Med Chem; 2005 May; 48(9):3319-27. PubMed ID: 15857137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.
    Williams JR; Khandoga AL; Goyal P; Fells JI; Perygin DH; Siess W; Parrill AL; Tigyi G; Fujiwara Y
    J Biol Chem; 2009 Jun; 284(25):17304-17319. PubMed ID: 19366702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors.
    Bandoh K; Aoki J; Taira A; Tsujimoto M; Arai H; Inoue K
    FEBS Lett; 2000 Jul; 478(1-2):159-65. PubMed ID: 10922489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
    Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
    Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor.
    Holdsworth G; Osborne DA; Pham TT; Fells JI; Hutchinson G; Milligan G; Parrill AL
    BMC Biochem; 2004 Aug; 5():12. PubMed ID: 15298705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.
    Wang DA; Lorincz Z; Bautista DL; Liliom K; Tigyi G; Parrill AL
    J Biol Chem; 2001 Dec; 276(52):49213-20. PubMed ID: 11604399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
    Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
    ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
    Li G; Mosier PD; Fang X; Zhang Y
    J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
    Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
    J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
    Noguchi K; Ishii S; Shimizu T
    J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.
    Tsukahara T; Tsukahara R; Yasuda S; Makarova N; Valentine WJ; Allison P; Yuan H; Baker DL; Li Z; Bittman R; Parrill A; Tigyi G
    J Biol Chem; 2006 Feb; 281(6):3398-407. PubMed ID: 16321982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors.
    Xu Y; Tanaka M; Arai H; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5323-8. PubMed ID: 15454220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.
    Durgam GG; Virag T; Walker MD; Tsukahara R; Yasuda S; Liliom K; van Meeteren LA; Moolenaar WH; Wilke N; Siess W; Tigyi G; Miller DD
    J Med Chem; 2005 Jul; 48(15):4919-30. PubMed ID: 16033271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
    Hama K; Aoki J
    Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.
    Yokoyama K; Baker DL; Virag T; Liliom K; Byun HS; Tigyi G; Bittman R
    Biochim Biophys Acta; 2002 May; 1582(1-3):295-308. PubMed ID: 12069841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.